A 32-week pregnant patient presents with symptoms of worsening pre-eclampsia, including elevated blood pressure, proteinuria, and elevated liver enzymes. Fetal assessment indicates potential intrauterine growth restriction (IUGR) and reduced fetal heart rate variability. Which of the following is the priority nursing intervention?

D) Arrange for continuous fetal heart rate monitoring to assess fetal well-being.

A) Administer antihypertensive medication to the mother to stabilize blood pressure.

B) Prepare the patient for immediate delivery to prevent further maternal and fetal complications.

C) Initiate corticosteroid therapy to promote fetal lung maturity.

D) Arrange for continuous fetal heart rate monitoring to assess fetal well-being.

A 32-week pregnant patient is diagnosed with worsening pre-eclampsia and possible HELLP syndrome. Which nursing intervention is the priority to prevent further maternal and fetal complications?

B) Administer antihypertensive medication as prescribed and monitor blood pressure closely.

A) Encourage the patient to remain on bed rest and monitor her urine output.

B) Administer antihypertensive medication as prescribed and monitor blood pressure closely.

C) Educate the patient on recognizing signs of labor and preterm labor symptoms.

D) Prepare the patient for immediate delivery to prevent further progression of complications.

A pregnant patient diagnosed with HELLP syndrome is admitted for observation. The healthcare team decides to start magnesium sulfate therapy. What is the primary nursing action when administering magnesium sulfate to this patient?

C) Assess the patient's respiratory rate every 30 minutes

A) Monitor the patient's deep tendon reflexes every 4 hours

B) Check the patient's blood pressure hourly

C) Assess the patient's respiratory rate every 30 minutes

D) Evaluate the patient's urine output every shift

A patient diagnosed with HELLP syndrome is admitted with a blood pressure of 170/110 mmHg, severe headache, blurry vision, and a platelet count of 110,000/mm³. Which nursing intervention should take priority to stabilize the patient's condition and prevent complications?

A) Administer magnesium sulfate as prescribed to prevent seizures.

B) Prepare the patient for an immediate cesarean delivery to resolve HELLP syndrome.

C) Initiate intravenous antihypertensive therapy to rapidly lower blood pressure.

D) Increase fluid intake to improve platelet count and liver function.

A patient with worsening preeclampsia and HELLP syndrome is scheduled for an emergency cesarean section. Which nursing intervention should be prioritized to ensure maternal and fetal safety prior to surgery?

C) Monitor fetal heart rate continuously and alert the team of any changes.

A) Administer an additional dose of magnesium sulfate to prevent seizures.

B) Prepare the patient for immediate delivery without further delay.

C) Monitor fetal heart rate continuously and alert the team of any changes.

D) Increase fluid intake to improve urine output and correct dehydration.

A patient with severe preeclampsia is being prepared for an emergency cesarean section due to deteriorating maternal and fetal conditions. Which nursing intervention is most critical to perform immediately before the surgery?

C) Ensure the patient has a patent IV access for fluid and medication administration.

A) Administer a bolus of magnesium sulfate.

B) Insert a Foley catheter to monitor urine output.

C) Ensure the patient has a patent IV access for fluid and medication administration.

D) Provide the patient and family with detailed education about the surgical procedure.

A postpartum patient who recently underwent an emergency cesarean section for preeclampsia with severe features, including HELLP syndrome, presents with a urine output of 20 mL/hr and a creatinine level of 1.9 mg/dL. Which nursing intervention is the priority to address the patient's acute kidney injury?

C) Monitor the patient's intake and output closely to guide fluid management.

A) Increase the rate of intravenous fluids to improve renal perfusion.

B) Administer antihypertensive medication to lower blood pressure.

C) Monitor the patient's intake and output closely to guide fluid management.

D) Prepare the patient for immediate hemodialysis to manage renal failure.

A patient with HELLP syndrome and preeclampsia is undergoing an emergency cesarean section. Despite magnesium sulfate therapy, the patient's reflexes remain brisk and she exhibits increased irritability. What is the most appropriate nursing intervention to prevent eclampsia in this scenario?

C) Notify the physician to consider the addition of antihypertensive therapy

A) Increase the magnesium sulfate infusion rate

B) Administer a bolus of intravenous diazepam

C) Notify the physician to consider the addition of antihypertensive therapy

D) Prepare for emergency intubation due to respiratory compromise

A postpartum patient with severe preeclampsia and HELLP syndrome is experiencing mild confusion and a persistent headache despite magnesium sulfate administration. Her blood pressure is 160/105 mmHg, and liver enzymes are elevated. Which nursing intervention is the priority to address her current symptoms?

B) Prepare for possible administration of antihypertensive medication

A) Increase the frequency of neurological assessments

B) Prepare for possible administration of antihypertensive medication

C) Monitor urine output and renal function closely

D) Assess for signs of magnesium sulfate toxicity

A postpartum patient in the ICU with a history of severe preeclampsia and HELLP syndrome exhibits mild confusion, persistent headache, elevated blood pressure, and rising liver enzymes. The healthcare team is considering the possibility of cerebral edema or intracranial hemorrhage. Which nursing intervention is most critical in managing this patient’s current condition?

B) Elevate the head of the bed to 30 degrees to reduce intracranial pressure.

A) Increase fluid intake to maintain adequate hydration.

B) Elevate the head of the bed to 30 degrees to reduce intracranial pressure.

C) Administer additional antihypertensive medication to lower blood pressure immediately.

D) Prepare for immediate intubation and mechanical ventilation.

obstetrics - Nursing Case Study

Pathophysiology

• Primary mechanism: Placental Insufficiency - Occurs when the placenta fails to deliver adequate oxygen and nutrients to the fetus, potentially leading to intrauterine growth restriction (IUGR) and fetal distress. Clinical relevance: Monitoring fetal growth and well-being is crucial to prevent adverse outcomes.

• Secondary mechanism: Pre-eclampsia - Characterized by hypertension and proteinuria after 20 weeks of gestation, resulting from abnormal placentation and systemic endothelial dysfunction. Clinical relevance: Early recognition and management are necessary to prevent progression to eclampsia, which can cause seizures and maternal complications.

• Key complication: Preterm Labor - Can be triggered by infection, stress, or uteroplacental ischemia, leading to cervical changes and uterine contractions before 37 weeks. Clinical relevance: Early intervention can improve neonatal outcomes by delaying delivery and enhancing fetal lung maturity.

Patient Profile

Demographics:

29-year-old female, school teacher

History:

• Key past medical history: Gestational diabetes in previous pregnancy, mild hypertension

• Current medications: Prenatal vitamins, labetalol for hypertension

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and shortness of breath

• Key symptoms: Swelling in the legs, occasional headaches, and blurred vision

• Vital signs: Blood pressure 150/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

During a routine prenatal visit at 32 weeks of gestation, the patient reports a significant increase in her fatigue and shortness of breath. Upon assessment, her blood pressure has escalated to 160/100 mmHg, and she exhibits new-onset proteinuria with a urine dipstick result showing 2+ protein. A follow-up 24-hour urine collection confirms proteinuria, with total protein levels reaching 350 mg. This development, alongside her elevated blood pressure, suggests worsening pre-eclampsia. Additional laboratory results reveal elevated liver enzymes, with AST at 45 U/L and ALT at 50 U/L, and a platelet count slightly decreased at 130,000/mm³, raising concerns about potential HELLP syndrome.

The patient's fundal height measurement indicates that fetal growth is lagging behind gestational age, pointing towards possible intrauterine growth restriction (IUGR) due to placental insufficiency. Fetal monitoring through a non-stress test reveals reduced variability in the fetal heart rate, prompting further evaluation with a biophysical profile and Doppler ultrasound to assess umbilical artery blood flow. The combination of maternal symptoms and fetal assessment findings highlights the need for intensified monitoring and potential intervention to mitigate risks to both mother and baby.

In response to these changes, the healthcare team discusses the importance of closely monitoring the patient's blood pressure, fetal well-being, and signs of labor progression. Given the increased risk of preterm labor and the potential need for early delivery, corticosteroids are administered to enhance fetal lung maturity. The team also considers hospitalization for closer observation and management, aiming to balance the risks of preterm birth against the dangers of advancing maternal and fetal complications. The patient is counseled on recognizing warning signs such as severe headaches, visual disturbances, or persistent abdominal pain, which would necessitate immediate medical attention.

Section 2

As the healthcare team continues to closely monitor the patient, the following morning reveals a concerning change in her status. The patient reports a severe, persistent headache and blurry vision, classic warning signs that were previously discussed with her. Her blood pressure has risen further to 170/110 mmHg, despite initial management efforts. Given the escalation in symptoms and blood pressure, the decision is made to admit the patient to the hospital for more intensive monitoring and management.

New diagnostic results obtained during her hospitalization include a repeat complete blood count showing a further drop in platelet count to 110,000/mm³, indicating progression towards more severe thrombocytopenia. Liver function tests also reveal a continued upward trend with AST now at 70 U/L and ALT at 75 U/L, further suggesting the advancement of HELLP syndrome. Fetal assessment via the biophysical profile scores a 6/10, with concerns about fetal movements and amniotic fluid volume, while Doppler studies show increased resistance in the umbilical artery, confirming the suspicion of placental insufficiency.

In light of these developments, the healthcare team must now carefully weigh the risks of continuing the pregnancy against the potential benefits of immediate delivery. The priority is to stabilize the mother's condition while ensuring fetal safety. The team decides to initiate magnesium sulfate therapy for seizure prophylaxis and intensifies corticosteroid therapy to further promote fetal lung development. The situation necessitates a multidisciplinary approach, involving obstetricians, neonatologists, and critical care specialists, to prepare for the potential delivery of the baby, as the risk of eclampsia and further fetal compromise looms.

Section 3

As the healthcare team continues to manage the patient's condition, they observe a change in her status that prompts immediate action. Despite the initiation of magnesium sulfate therapy, the patient begins exhibiting increased deep tendon reflexes, a potential warning sign of inadequate seizure prophylaxis. Her blood pressure remains elevated at 168/108 mmHg, and slight confusion sets in, indicating possible progression toward eclampsia. The fetal heart rate monitor shows persistent late decelerations, and the biophysical profile score drops to 4/10, exacerbating concerns about fetal well-being and necessitating a reevaluation of the plan of care.

The laboratory team reports new results showing a further decline in platelet count to 95,000/mm³, and liver enzymes continue to rise, with AST at 85 U/L and ALT at 82 U/L, confirming the progression of HELLP syndrome. The patient's urine output decreases to 20 mL/hour, and proteinuria remains significant, adding to the clinical picture of worsening preeclampsia. Doppler studies reveal further increased resistance in the umbilical artery, suggesting deteriorating placental perfusion, which raises the urgency to expedite delivery for both maternal and fetal safety.

Given these developments, the healthcare team concludes that the risks of continuing the pregnancy outweigh the benefits. After a thorough discussion with the patient and her family, the decision is made to proceed with an emergency cesarean section. The team prepares for the potential challenges of delivering a preterm infant, coordinating with neonatologists to ensure immediate neonatal care. The goal is to stabilize both mother and child, mitigate the risk of seizures, and address the ongoing complications of HELLP syndrome effectively, setting the stage for the next phase of intensive care and recovery.

Section 4

As the team proceeds with the emergency cesarean section, they closely monitor the patient's vital signs and response to interventions. During the initial assessment in the operating room, the patient's blood pressure remains elevated at 170/110 mmHg, and she exhibits increased irritability, an indication that seizure prophylaxis may need to be intensified. Despite the magnesium sulfate therapy, her reflexes remain brisk, necessitating consideration of alternative measures to prevent eclampsia. The anesthesiology team carefully administers spinal anesthesia, maintaining vigilance for any signs of neurological compromise, while also preparing for potential complications from the patient's low platelet count, which poses a risk for bleeding during surgery.

Intraoperative findings reveal a compromised placenta with signs of abruption, correlating with the prior Doppler studies that indicated poor placental perfusion. The neonatologists stand ready as the preterm infant is delivered, exhibiting signs of distress with Apgar scores of 4 and 6 at one and five minutes, respectively. Immediate neonatal resuscitation is initiated, with positive pressure ventilation and supplemental oxygen. The infant's heart rate stabilizes post-intervention, but the need for NICU admission is evident. Meanwhile, the surgical team manages to control bleeding effectively, utilizing packed red blood cells and platelets to address the potential for coagulopathy associated with HELLP syndrome.

As the case progresses, the patient's urine output remains low, prompting further evaluation of her renal function. Post-operatively, her lab results reveal a creatinine level of 1.9 mg/dL, confirming acute kidney injury likely secondary to preeclampsia and HELLP syndrome. The healthcare team focuses on maintaining hemodynamic stability, optimizing fluid management, and adjusting medications to support renal recovery while minimizing further hepatic injury. The plan includes ongoing monitoring and collaboration with nephrology to prevent progression to more severe renal compromise. The patient is closely observed in the intensive care unit, where efforts are concentrated on stabilizing her condition, managing HELLP syndrome complications, and ensuring the best possible outcomes for both mother and child.

Section 5

As the patient continues her recovery in the intensive care unit, her condition is closely monitored for any changes that may indicate further complications. On the second postoperative day, the healthcare team notes a change in her neurological status. The patient begins to experience mild confusion and reports a persistent headache, which could suggest the onset of eclampsia despite the ongoing administration of magnesium sulfate. Her blood pressure remains elevated at 160/105 mmHg, and her reflexes continue to be brisk. Given these concerning signs, the medical team decides to increase the magnesium sulfate dosage and consults neurology for further evaluation, considering the possibility of cerebral edema or intracranial hemorrhage as a complication of severe preeclampsia.

Simultaneously, new laboratory results reveal a further increase in liver enzymes, with AST and ALT levels rising to 280 U/L and 250 U/L, respectively. These findings suggest a worsening of the HELLP syndrome, necessitating a reassessment of the patient's hepatic function and potential adjustments in her treatment plan. The patient's platelet count remains low at 80,000/µL, which raises concerns about her risk for bleeding. The team collaborates with hematology to determine the need for additional platelet transfusions and explores the use of corticosteroids to stabilize her condition.

In light of these developments, the healthcare team prioritizes a multidisciplinary approach to prevent further deterioration. The focus remains on maintaining blood pressure control, preventing seizures, and supporting liver and kidney function. The case underscores the complexity of managing postpartum complications in the context of severe preeclampsia and HELLP syndrome, highlighting the need for vigilant monitoring and timely interventions to ensure the patient's continued recovery and the long-term well-being of the neonate. The evolving scenario sets the stage for ongoing assessment and potential adaptation of the care plan based on the patient's dynamic response to treatment.